Completed Enrollment

A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)]

The main purpose of this study is to determine the efficacy and safety of LY3819469 in adults with elevated lipoprotein (a).

Trial Summary

Age Range
≥40 years
Conditions the trial is for
Lipoprotein Disorder
What the trial is testing?
LY3819469
Could I receive a Placebo?
Yes
Enrollment Goal
216
Trial Dates
Oct 20, 2022 - Oct 2024
How long will I be in the trial?
The study will last about 20 months and may include up to 13 visits.
Trial Phase
II

Key Requirements

Clinical trials have inclusion and exclusion requirements to determine which individuals qualify for participation. Listed below are key requirements for this clinical trial, but there may be additional requirements to qualify.

Participants Must:

  • Participants must be at least 40 years old and have Lp(a) level≥175 nmol/L at screening

  • Participants if on lipid-lowering drugs or hormone therapy need to be on stable dose for at least 4 weeks prior to screening

  • A body mass index within the range 18.5 to 40 kilogram/square meter 

  • Males who agree to use highly effective contraception methods or women not of childbearing age

Participants Must Not:

  • Have a history or presence of an underlying disease, or surgical, physical, medical, or psychiatric condition that in the opinion of the investigator, would affect participant safety within the study or interfere with participating in or completing the study or with the interpretation of data.

  • Had major surgery within 3 months of day 1

  • Had coronary, carotid, or peripheral arteria revascularization, stroke, heart attack or chest pain within 3 months of day 1

  • Have uncontrolled diabetes

  • Have uncontrolled high blood pressure

  • Women of childbearing potential

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.

Clinical Trial Resources

Cardiovascular (Heart Disease) Research

By volunteering to take part in Cardiovascular clinical trials, you may be able to play an important role in the research and development of potential new treatments and medicines. We understand that when you or a loved one take part in a clinical trial, it is a big decision. It is important for you to understand why the research is being carried out and what taking part will mean for you. Learn more about Lilly

Cardiovascular Research

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study. It helps us learn if a new medicine or treatment works and how it works. Clinical trials can also be called clinical research studies. Learn more about clinical research studies and what to expect when taking part in a clinical trial.